237 related articles for article (PubMed ID: 30159726)
1. pN status predicts outcomes in surgically treated pT1-pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.
Qian X; Sinikovic B; Schreiber F; Ochsenreither S; Klinghammer K; Wollenberg B; Kaufmann AM; Albers AE
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2787-2795. PubMed ID: 30159726
[TBL] [Abstract][Full Text] [Related]
2. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.
de Juan J; García J; López M; Orús C; Esteller E; Quer M; León X
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):483-8. PubMed ID: 23681031
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
7. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
Amit M; Liu C; Gleber-Netto FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Baruch EN; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
Cancer; 2021 Apr; 127(8):1238-1245. PubMed ID: 33320343
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
10. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
11. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
[TBL] [Abstract][Full Text] [Related]
12. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of head and neck squamous cell carcinoma patients with N3 neck disease treated primarily with chemoradiation versus surgical resection.
Smyth JK; Deal AM; Huang B; Weissler M; Zanation A; Shores C
Laryngoscope; 2011 Sep; 121(9):1881-7. PubMed ID: 21997727
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.
Wang Y; Yang R; Zhao M; Guo W; Zhang L; Zhang W; Wang X
World J Surg Oncol; 2020 May; 18(1):90. PubMed ID: 32375789
[TBL] [Abstract][Full Text] [Related]
16. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.
Briganti A; Karnes RJ; Da Pozzo LF; Cozzarini C; Capitanio U; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Di Muzio N; Rigatti P; Montorsi F; Blute M
Eur Urol; 2011 May; 59(5):832-40. PubMed ID: 21354694
[TBL] [Abstract][Full Text] [Related]
17. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
[TBL] [Abstract][Full Text] [Related]
19. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
[TBL] [Abstract][Full Text] [Related]
20. Oral Cancer in the Indian Subcontinent-Survival Outcomes and Risk Factors with Primary Surgery.
Thakar A; Thakur R; Kakkar A; Malhotra RK; Singh CA; Sikka K; Kumar R; Pramanik R; Biswas A; Bhalla AS; Bhaskar S; Sharma A
Laryngoscope; 2021 Oct; 131(10):2254-2261. PubMed ID: 33797083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
